Average Co-Inventor Count = 5.43
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Denali Therapeutics Inc. (24 from 51 patents)
2. Roche Palo Alto LLC (20 from 322 patents)
3. Genentech, Inc. (15 from 3,221 patents)
4. Novartis Ag (11 from 3,923 patents)
5. Sfunga Therapeutics, Inc. (3 from 3 patents)
6. F. Hoffmann-la Roche Ag (2 from 168 patents)
7. Enanta Pharmaceuticals, Inc. (1 from 290 patents)
8. Medical Research Council Technology (1 from 3 patents)
75 patents:
1. 12358928 - Compounds, compositions and methods
2. 12358896 - LRRK2 inhibitors and methods of making and using thereof
3. 12180211 - Compounds, compositions and methods
4. 12139478 - Compounds, compositions and methods
5. 12129263 - Kinase inhibitors and uses thereof
6. 11851433 - Compounds, compositions and methods
7. 11851440 - Modulators of eukaryotic initiation factor 2B, compositions and methods
8. 11840529 - Substituted pyrimidines as LRKK2 inhibitors
9. 11834439 - Compounds, compositions, and methods
10. 11591316 - Compounds, compositions, and methods
11. 11236100 - Modulators of eukaryotic initiation factor 2B, compositions and methods
12. 11214565 - Compound, compositions, and methods
13. 11203600 - Kinase inhibitors and uses thereof
14. 11174262 - Compounds, compositions and methods
15. 11111235 - Compounds, compositions, and methods